After falling for three straight years on declining sales of hepatitis C drugs, Gilead Sciences’ (GILD) revenues finally seemed to bottom last year, …

Has perspective been lost in these chaotic times? People have been emptying supermarkets by stocking up on the essentials, with the bizarre scenes …

The market’s sell-off has put some solid stocks on sale, none more so than those in the embattled finance sector. Year-to-date, the BKX …

Friday closed with a flourish of buying, as the President called a national State of Emergency, regarding the coronavirus spread. The sharpest daily …

It’s (almost) official, folks: We have (kind of) a bear market! With the Dow Jones Industrial Average falling as much as 20% below …

The effect of the coronavirus on the global economy has seen the markets suffer their worst week since the financial crisis. The fallout …

Tesla (TSLA) stock was down 43% between the beginning of the year and June 3rd — but is now up 43% since then. …

It’s been puzzling to me to read or listen to some of the commentary associated with the deal Canopy Growth (CGC) made to …

The recent announcement by Aurora Cannabis (ACB) that it won a two-year medical supply contract in Italy, reinforces the fact it’s becoming the …

While this has certainly been an action-packed week in the marijuana industry, perhaps the biggest news is that Curaleaf Holdings (CURLF) has acquired …